MaxCyte, Inc. (MXCT) Revenue Growth
MaxCyte, Inc. (MXCT) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 30.59% |
| 2023-12-31 | -6.72% |
| 2024-12-31 | -6.44% |
| 2025-12-31 | -14.50% |
How MXCT compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| MYGN | Myriad Genetics Inc. | -1.56% |
| PRGO | Perrigo Company plc | -2.75% |
| OGN | Organon & Co. | -2.92% |
| ENTA | Enanta Pharmaceuticals Inc. | -3.42% |
| DYAI | Dyadic International Inc. | -11.59% |
These are five companies in the same sector as MXCT with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get MaxCyte, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("MXCT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MXCT | $1.24 | -3.88% | 0.68M |
| 3 | ||||
| 4 | ||||
| 5 |